Shares in Novo Nordisk (NYSE: NVO) fell more than 4% following the market open on Friday after the Danish pharma giant released data from a phase 2a clinical trial with its obesity drug, monlunabant.
Evercore ISI hiked its price target for Amazon.com (NASDAQ: AMZN) shares from $225 to $240 and maintained an Outperform rating. The revised target is based on a 35x multiple of the firm's projected ...
Yet, for some reason, the Fed and other regulators have decided to significantly reduce planned increases in capital requirements. Yet, amazingly, the mainstream media and research agencies have ...